Table 1 Clinical and biochemical parameters of patients with SAT compared to healthy control subjects

Gender, female/male: number (percentage)

33 (66%)/17 (34%)

47 (79.7%)/12 (20.3%)

0.108

Age (years)

40.41 ± 13.14

44.36 ± 11.01

0.102

Selenium (µg/L) (63–160 mcg/L)

64.20 (39.21–106.80)

69.10 (24.60–130.20)

0.121

TSH (0.38–5.33 uIU/mL )

1.87 (0.41–5.50)

0.020 (0.003–0.37)

< 0.001

fT4 (0.60–1.25 ng/dl )

0.85 (0.68–1.10)

1.63 (0.69–4.25)

< 0.001

fT3 (2.28–4 pg/ml)

3.00 (2.05–3.71)

4.89 (2.44–13.46)

< 0.001

Anti-TPO positivity (n/%)

5 (10%)

3 (5.1%)

0.446

Anti-Tg positivity (n/%)

6 (12%)

2 (3.4%)

0.139

ESR

7 (1–22)

49 (9–120)

< 0.001

CRP (0–8 mg/L )

1.24 (0.12–22.47)

45.7 (4.68–172)

< 0.001

WBC (3570–11010 n/µL )

7095 ± 1689

8613 ± 2464

< 0.001

Neutrophils (1690–7550 n/µL )

4134 ± 1327

5788 ± 2036

< 0.001

Lymphocytes (880–2890 n/µL)

2338 ± 845

2031 ± 643

0.043

NLR

1.66 (0.73–7.00)

2.94 (0.79–8.36)

< 0.001

Thyroid volume (cm³)

12.25 ± 4.13

22.11 ± 10.83

< 0.001

Pain Score (0–10)

7 (5–10)